Dr. Roger Lo awarded NIH grant to tackle melanoma treatment resistance
University of California, Los Angeles (UCLA), Health SciencesUCLA's Dr. Roger Lo was awarded a $2 million grant from the National Institutes of Health to investigate innovative strategies to prevent drug resistance in melanoma treatment and improve the effectiveness of MAPK inhibitors, a common treatment for patients with melanomas that carry the BRAFV600 mutation.